Walleye Trading
OPRX icon

Walleye Trading’s OptimizeRx OPRX Stock Holding History

Walleye Trading’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,887
Closed -$133K – 4704
2025
Q2 		$133K Buy
+9,887
New +$108K ﹤0.01% 3455
2022
Q3 		– Sell
-181
Closed -$5K – 5384
2022
Q2 		$5K Buy
+181
New +$5.36K ﹤0.01% 4779

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Walleye Trading's OPRX Position: Q3 2025 in Review

Walleye Trading sold out of OptimizeRx (OPRX) in Q3 2025, closing a stake of 9,887 shares — an estimated $133K sold.

Walleye Trading first reported a position in OPRX in Q2 2022 and held it in 2 quarters. The position peaked at $133K in Q2 2025. 125 funds tracked by Wall St. Rank hold OPRX as of Q3 2025.

  • Walleye Trading reported no remaining OptimizeRx position as of Q3 2025 after selling out during the quarter.
  • Walleye Trading sold 9,887 OptimizeRx shares in Q3 2025, an estimated $133K.
  • Walleye Trading first reported a position in OptimizeRx in Q2 2022 and held it in 2 quarters.
  • Walleye Trading's OptimizeRx position peaked at $133K in Q2 2025.
  • 125 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2025.

Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.